dr. triebel on novel immunotherapy combination in melanoma
Published 5 years ago • 130 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:42
dr. triebel on the rationale for a novel immunotherapy combination in melanoma
-
1:29
the future of novel immunotherapy combinations in melanoma
-
7:48
immunotherapy combinations in advanced melanoma
-
5:28
novel combinations for metastatic melanoma
-
2:37
a novel way to test cancer immunotherapy combinations
-
7:00
novel immunotherapy combinations in nsclc
-
2:01
dr. ribas on combination immunotherapy and radiation in melanoma
-
4:00
valerie's story: valerie shares how she beat her malignant melanoma
-
39:06
expanding the benefits of immuno-oncology through novel rational targets and combinations
-
10:22
melanoma and braf (pronounced “be-raf”)
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
1:16
dr. weber on emerging immunotherapy combinations in melanoma
-
1:02
dr. wenham on rationale for novel immunotherapy combos in ovarian cancer
-
1:42
novel triple combination therapies for melanoma
-
2:20
novel immunotherapy combinations for nsclc
-
1:14
dr. daud on the combinations of immunotherapy for melanoma
-
1:04
optimizing tils as a novel immunotherapy strategy in metastatic melanoma
-
30:34
melanoma and immunotherapy with dr. margaret callahan and sharon belvin
-
2:12
novel immunotherapeutic approaches to treat patients with melanoma
-
1:20:31
choosing innovation with immunotherapy in melanoma
-
0:45
immunotherapy basics in melanoma
-
1:09
vidutolimod, a novel tlr9 agonist, in high-risk resectable melanoma